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Studies have proposed that Porphyromonas gingivalis (Pg) and Tannerella forsythia (Tf) promote a nonspecific inflammatory
response that could produce systemic disease. Oral inoculation of Pg and Tf on the immune and arthritis response was evaluated in
BALB/Cmice divided into four groups: (1) sham; (2) food contaminated with Pg/Tf ; (3) complete Freund’s adjuvant (CFA) + Pg/Tf ;
and (4) CFA alone. CFA was administered subcutaneously on days 1 and 14. The arthritis response was monitored for 21 days after
day 14 of CFA administration. IL-1𝛽 and IL-6 were determined in serum. T cell activation was evaluated by CD25 in salivary lymph
nodes or mouse spleen. Pad inflammation appeared by day 19 in the CFA group, but animals with bacteria inoculation presented a
delay. A significant increase in IL-6 was found in Groups 3 and 4, but not with respect to IL-1𝛽. We observed an increase in CD25
in cells derived from cervical nodes and in animals with bacteria inoculation and CFA. A local immune response was observed
in mice inoculated with Pg and Tf (T cell activation); a systemic response was observed with CFA. Since pad inflammation was
delayed by bacterial inoculation this suggests that local T cell activation could decrease pad inflammation.
1. Introduction
Rheumatoid arthritis (RA) is an autoimmune joint disease
that results in painful joint deformity and immobility [1]. It is
characterized by symmetrical polyarticular inflammation of
small and large joints with systemic involvement. Its annual
incidence worldwide is about 40/100,000 with a lifetime risk
of RA in women of 3.6%.The disease is also more frequent in
women with a ratio of 2 : 1 to 3 : 1 [2].
The oral microbiota includes pathogens species that
normally cause infections limited to the oral cavity; however,
when these microorganisms or their components enter the
circulation or connective tissues, they can activate a local or
systemic immune response. In particular, chronic alterations
in the sulcusmicrobiota balance could induce a very common
inflammatory disease called periodontitis which suggests an
unbalance between beneficial and pathogenic oral bacteria
that induce inflammation and structural destruction of the
support systemof the tooth [3]. In recent years, several studies
suggest that periodontitis could favor systemic diseases, such
as RA [4–6]. In this regard, some experimental studies
in animal models have confirmed that oral infection with
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Table 1: Inflammatory response of the hind limbs of Balb/c mice.
Groups Hind limb swelling (mm) Hind limb thickness (mm)
Sham group+
Sham+ R: 1.4-L: 1.4 R: 2-L: 2
Sham+ R: 1.4-L: 1.4 R: 2-L: 2
Sham+ R: 1.4-L: 1.4 R: 2-L: 2
Group 2 sham− R: 1.4-L: 1.4 R: 2-L: 2
P. gingivalis plus T. forsythia R: 1.4-L: 1.4 R: 2-L: 2
P. gingivalis. plus T. forsythia R: 1.4-L: 1.4 R: 2-L: 2
Group 3 R: 1.4-L: 1.4 R: 2.5-L: 2.5
P. gingivalis plus Freud adjuvant R: 1.4-L: 1.4 R: 2.5-L: 2.5
P. gingivalis plus Freud adjuvant R: 1.4-L: 1.4 R: 2.5-L: 2.5
Group 4 R: 1.4-L: 1.4 R: 2.5-L: 2.5
Freud adjuvant R: 1.5-L: 1.5 R: 2.5-L: 2.5
Freud adjuvant R: 1.4-L: 1.4 R: 2.5-L: 2.5
R = right; L = left.
P. gingivalis or T. forsythia is capable of activating an immune
response and modulating arthritis development [7, 8]; how-
ever, the inducing mechanisms remain obscure.
Several basic and clinical studies have proposed that the
periodontopathogenic bacteria P. gingivalis can secrete an
enzyme with peptidyl arginine deiminase activity that could
modify host peptides and proteins favoring, in theory, an
autoimmune disorder [9]. Similarly, other posttranslational
protein modifications such as carbamylation could favor
alterations in the immune response and potentially explain
the development of systemic disorders [10]. In this respect,
it is critical to understand the routes by which the oral
microenvironment could exert an influence on the local
immune response as a strategy that explains subsequent
systemic disorders. Our goal in this study was to evaluate
in a subchronic murine model if bacteria inoculation alone
was enough to induce immunological effects or modulate
experimental arthritis inflammation.
2. Materials and Methods
Male BALB/C mice, 8–12 weeks of age, were used for the
development of experimental arthritis. Four experimental
groups of three mice each were formed: (1) sham; (2) inoc-
ulation with P. gingivalis (Pg)/T. forsythia (Tf); (3) complete
Freund’s adjuvant + inoculation with Pg/Tf ; and (4) Freund’s
complete adjuvant alone.
Trypticase soy broth supplemented with hemin and vita-
min k was prepared for culturing P. gingivalis and T. forsythia.
Bacteria were first activated in an anaerobic chamber. After
activation, bacteria were cultured at 37∘C for 24 hrs [11].
Subsequently, the bacteria were inoculated into the food by
immersion in growth culture. The food mixture was allowed
to dry for at least 2 days in an anaerobic chamber. Clean and
contaminated food were distributed in 50 g aliquots, which
were changed at the beginning of each week. On day 14, 10 𝜇L
of contaminated culture medium was inoculated by pipette
into the oral cavities of the two groups that would receive
50 𝜇L of contaminated food (Group 2 [Pg/Tf] and Group 3
[CFA + Pg/Tf ] every other day until the end of the study).
Bacterial density was 0.5 McFarland standard as defined in
the CLSI standard [12].
To induce experimental arthritis, two subcutaneous in-
jections of 50 𝜇L of complete Freund’s adjuvant (CFA) [Myco-
bacterium tuberculosis extract, 1mg/mL] (Sigma-Aldrich, St.
Louis, MO) were applied at the base of the tail of the mice in
Groups 3 and 4 on days 1 and 14 [13].
Evaluation of the inflammatory events was performed
with a vernier every third day for thirty-five days. The extent
of swelling of the hind limbs was measured from the mouse
heel to the base of the phalanges; thickness was measured
in mm from the anterior to the posterior part of the paw
(Table 1). Movement monitoring was classified according to
an arbitrary system comprising 4 different levels, expressing
results as an arithmetic mean. Additionally, the body weight
of the animals was monitored every two to three days.
On days 14 and 35, saliva samples were obtained with
sterile swabs to confirm the presence of the inoculated
bacteria. Confirmation was achieved by observation in a
Neubauer chamber. First, the swabs of each group were
placed in Eppendorf tubes with trypticase soy to perform the
bacterial count. These samples were left at 37∘C for 24 hrs.
After 24 hours, 1𝜇L of the suspension was placed on a slide
using a pipette, filling the counting chamber by capillarity;
bacterial cells were counted in one of the larger 25 frames.
Gram-staining was performed to demonstrate the presence
of bacteria. Real-time qPCR was performed to determine
bacterial viability. Virulence genes controlled by the luxS
gene in P. gingivalis were measured to confirm viability and
their natural condition since these cultures can modify their
virulence expression patterns.This is becausemicrobiological
handling is complicated and can affect growth efficiency in
culturemedia [14]. For this experiment the following primers
were used: For P. gingivalis, CGGAGCCGGAAAGAAGG
(forward), GCAGCACCCACGTAAAGAACAG (reverse),
for T. forsythia, GCGTATGTAACCTGCCCGCA (forward),
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GAAGGCAGCTTACTAAGG (reverse), and as a control,
GAPDH, TTGGAACTGGAACACGTTGTG (forward) and
TAAAGCTATTGGTCTTGTTCCTG (reverse).
At the end of 35 days, the mice were sacrificed. Serum
samples were obtained by intracardiac puncture and after
clotting, the serum was recovered by centrifugation. Sam-
ples were kept at 4∘C until analysis on the following day.
Additionally, spleen and cervical nodes were recovered from
each group and processed to obtain pooled cell samples.
ELISA was performed to determine IL-1𝛽 and IL-6 levels
(Peprotech Mexico S.A de C.V., Mexico City, Mexico). To
evaluate expression of the activation marker CD25 in spleen
and lymph node lymphocytic cells, tissues were isolated after
sacrifice of the mice; cells were separated from tissue and
fixed with 1% paraformaldehyde. The following day, these
cells were incubated with FITC-coupled antibody anti-CD25
(Pharmagen, Lahore, Pakistan). Analysis was done on a
FACscalibur flow cytometer.
3. Results
3.1. Arthritis Model. The mobility of the animals and body
weight in the 4 groups were monitored as indirect markers
of inflammation of CFA treatment. As seen in Figure 1(a),
statistically, body weight did not differ between Groups 1
(7.49 ± 2.42 g), 3 (5.64 ± 0.35 g), and 4 (6.26 ± 4.2 g). In
contrast, the group inoculated only with Pg/Tf showed a
greater increase in body weight (12.56 ± 0.56 g). Otherwise,
the mobility of animals was significantly different between
groups (Figure 1(b)), showing that groups treated with CFA
lose mobility just after the second immune challenge (day
19) until the end of the experiment (day 35). Interestingly,
the group receiving oral treatment with bacteria showed
a significant delay in the loss of displacement potentially
suggesting a minor inflammatory status.
The hind legs of the experimental animals were also
evaluated based on the change in thickness. Neither the
sham group nor the group inoculated with Pg/Tf showed
any variation in hind leg thickness. The group of animals
treated with CFA showed no statistically significant increase
up to day 5 of treatment, but after day 19, the increase
was statistically significant. This change coincides with the
effect in response to the second application of CFA (day 14)
(Figure 1(c)). Finally, the CFA group inoculated with Pg/Tf
showed no increase in foot pad thickness during the first
19 days of the experiment; however, by day 24, all showed
a significant increase, similar to the effect of the group
treated only with CFA. This seems to suggest that bacterial
inoculation somehow decreases the propensity for moderate
inflammation (window between 5–22 days) and delays the
onset of the increase in thickness (day 19 to 24).
3.2. Immunological Effects of Oral Bacteria. In order to
evaluate the effect of oral inoculation of bacteria strains on
the immune response, plasma levels of two inflammatory
cytokines, IL-1𝛽 and IL-6, were determined. As shown in
Figure 2(a), IL-6 levels were statistically similar between
Groups 1 (sham) and 2 (bacterial inoculation). Group 4 (CFA)
showed a significant increase in IL-6 levels compared to the
sham or bacterial inoculation groups (𝑝 < 0.05), despite
the fact that it was the experimental group where there was
greater variation in the results. The group of mice treated
withCFA and bacterial inoculation also showed increased IL-
6 levels with a significantly higher mean than that observed
in the sham group (𝑝 = 0.0262). It is noteworthy that the
mean concentration of serum IL-6 levels was lower in the
case of animals in Group 3 compared to Group 4, although
no statistical significance was reached.
IL-1𝛽 serum levels were not significantly altered between
the different experimental groups, showing a variation be-
tween 47 and 82 pg/mL (Figure 2(b)). Although a slight
increase in cytokine levels in Group 3 (CFA + Pf/Tf ) was
observed, the standard deviation of the different groups can-
cels any proposed difference. Additional statistical analyses
by theKruskal-Wallis test showedno significant differences in
IL-1𝛽 levels due to the effect of CFA or bacterial inoculation.
In order to evaluate possible effects on the activation of
immune system cells, lymphoid cells derived from cervical
nodes and the spleens of animals were analyzed according to
the percentage and relative surface presence of the activation
marker CD25 (Figure 3). Evaluation of splenocyte prepara-
tions resulted in similar CD25 levels in comparison to sham
animals, suggesting that oral inoculation of P. gingivalis and
T. forsythia during 35 days was not enough to induce systemic
activation of T cells (data not shown).Otherwise, in lymphoid
cells derived from cervical nodes, we clearly observed an
activation effect. In comparison to the sham group, animals
inoculated only with bacteria (Group 2) showed an eightfold
increase of CD25 levels (5.27 versus 41.52%). However,
animals treated only with CFA in the absence or presence of
oral bacteria showed a higher percentage of CD25-positive
cells (89.03% and 96.90%, resp.), confirming that a complete-
adjuvant challenge exerts strong immune system stimulation.
Although this was not significantly different, animals treated
with CFA and bacteria inoculation showed the highest levels
of CD25, suggesting that oral bacteria could exert additional
stimulation. It is noteworthy that only oral inoculation of P.
gingivalis and T. forsythia was enough to stimulate local but
not systemic lymphocytes, suggesting that oral microbiota
disorders can potentially alter the immune response, even if
systemic symptoms are not observed.
4. Discussion
Periodontal colonization of pathogenic bacteria (P. gingivalis
and T. forsythia) clearly showed pathogenic and inflamma-
tory effects on the host oral microenvironment [15, 16] but its
consequences on the systemic host immune response remains
poorly studied. In this regard, some studies have shown that
periodontitis can induce platelet aggregation and activation
[17], together with an increase in the levels of inflammatory
cytokines such as IL-6 and TNFa [18, 19]. Additionally,
some studies have shown, as a response of periodontitis,
chemotaxis and activation of neutrophils or monocytes [19,
20], suggesting a very dynamic and modulated communica-
tion between the oral microenvironment and the immune
system [21]. Additionally, these results come to support the
hypothesis that proposes that chronic oral disease could favor
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Figure 1: (a) Effect of treatment with CFA and bacterial inoculation on change in body weight of experimental animals. The results of 3
animals per group, the mean and standard deviation are shown. To determine the change in body weight of each animal, the difference was
obtained between the weight at the start of the experiment (day 0) and at the end of the experiment (day 35). The evaluation was performed
based on a dichotomous criterion: normal mobility and decreased mobility. With the Kruskal-Wallis test, the difference between the groups
did not reach statistical significance (𝑝 = 0.0784), although the change in body weight of Group 2 seemed to be greater in relation to the
other groups. (b) Effect of treatment with CFA and bacterial inoculation on loss of mobility. Results of 3 animals per group; the mean and
standard deviation are shown. To determine the change of mobility of each animal, each evaluation was performed based on a dichotomous
criterion: normal mobility and reduced mobility. Solid black line, sham (Group 1); black dashed line, sham + Pg/Tf (Group 2); blue dashed
line, CFA + Pg/Tf (Group 3); red dashed line, CFA alone (Group 4). A loss of mobility was observed from day 19 in the CFA group, while
the loss of mobility was complete in the CFA + Pg/Tf group starting on day 24 of the study. (c) Effect of treatment with CFA and bacterial
inoculation on hind leg thickness. Results correspond to the mean and standard deviation of the two hind limbs of 3 animals per group. The
change in thickness (ΔThickness) was determined based on the difference between the initial thickness of the foot pad and thickness during
the different study times. Solid black line, sham (Group 1); black dashed line, sham + Pg/Tf (Group 2); blue dashed line, CFA + Pg/Tf (Group
3); red dashed line, CFA alone (Group 4). The group treated with CFA without Pg/Tf showed an increase in thickness after day 19. The group
treated with CFA and with Pg/Tf showed a delayed increase (day 24).
systemic inflammatory disorders such as rheumatoid arthritis
[22, 23].
In order to characterize the biological mechanisms
employed by the oral microenvironment in the host immune
response, we proposed to evaluate their effect in a subchronic
CFA-induced arthritis model. First, CFA induced an increase
in footpad thickness which caused a decrease in mobility
with and without inoculation of P. gingivalis and T. forsythia
(Figure 1). Additionally, increased serum levels of IL-6, but
not of IL-1𝛽, were observed. Although slightly lower levels
were observed, the group treated with CFA and inoculated
with themixture of bacteria also showed increased IL-6 levels.
Bacterial inoculation, without treatment with CFA, resulted
in a significant increase in the percentage of CD25+ cells
derived from cervical lymph nodes, but not from spleen-
derived cells. On the other hand, treatment with CFA also
caused a significant increase in the percentage of CD25+
cells in Groups 3 (97%) and 4 (86%). However, it did not
alter systemic immunological variables (spleen). The greatest
inflammatory (or in less time) effect in mice was found in
International Journal of Dentistry 5
Group 1 Group 2 Group 3 Group 4
0.05
0.07
0.09
0.11
0.13
0.15
IL
-6
 (n
g/
m
l)
(a)
Group 1 Group 2 Group 3 Group 4
0.05
0.07
0.09
0.11
0.13
0.15
IL
-1
𝛽
(n
g/
m
l)
(b)
Figure 2: (a) Effect of the inoculation of periodontopathogenic bacteria on serum IL-6 levels. The values shown are the mean of three mice
analyzed by study group plus their respective mean. Group 1: untreated sham; Group 2: mice inoculated with Pg/Tf ; Group 3: inoculated
intradermally with CFA + Pg/Tf ; and Group 4: CFA inoculated intradermally.These values show a significant increase in IL-6 levels of Group
1 versus Group 2, although a significant difference was not demonstrated (𝑝 = 0.128) in contrast with Group 3 (𝑝 = 0.0262). A significant
difference was found in Group 1 versus Group 4 (𝑝 = 0.0555). (b) Effect of the inoculation of periodontopathogenic bacteria on serum levels
of IL-1𝛽. Murine blood was drawn on day 35 after euthanasia and was centrifuged and analyzed the next day. IL-1𝛽 in the supernatant was
determined by ELISA. Groups: 1, 2, 3, 4. Bars represent the mean ± standard deviation of three replicates from three animals per group; these
did not show statistically significant increases. PRISM v.6.0 was used for data analysis.
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Figure 3: Flow cytometry of the frequency of regulatory T cells (CD25+) induced by Pg/Tf, CFA in BALB/c mice.
Group 4. This could suggest that inoculation of periodon-
topathogenic bacteria modulates the inflammatory response
in this experimental murine model. This is similar to the
results of Bartold et al. [5] who observed established chronic
inflammation with increased limb length. In our study, the
hind limbs showed an increase in diameter one week after the
second immunization with CFA. Also, in a previous study by
Barajas-Torres [4], inflammation of the anterior and posterior
joints was produced in mice immunized with the thymic
hormonal factor, tactivin, compared to controls. Different
studies state the need to increase the observation time after
immunization or increase the number of applications with
CFA with the aim of determining the inflammatory response
[6, 20, 24].
Additionally, we observed a higher prevalence of arthritis
in the group inoculated with Pg/Tf and in the group with
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Pg/Tf plus CFA, similar to the research by Kinloch et al. [25]
who found increased ankle thickness in mice after a second
inoculation with CFA.
Although we observed a significant increase in IL-6 levels
in the course of the experiment, it may be necessary to
increase the length of time and number of immunizations
or the application of a new inflammatory inductor to find
changes in IL-𝛽 levels. Since several studies have confirmed
the critical role played by IL-1𝛽 in the innate immune
response [26], it is not clear why we did not observe
alterations due to the application of CFA or if there was an
affect caused by bacterial inoculation.
On the other hand, it is unclear whether or not chronic
oral infection with P. gingivalis should occur prior to CFA
application. In this respect, employing a chronic murine
model of P. gingivalis infection prior to arthritis induction,
Marchesan et al. described an increased activation of the
immune system that favors regulatory T cell responses, which
ultimately would accelerate the development of arthritis [27].
This suggests that chronic oral infection can influence the
development of RA primarily through activation of pathways
related toTh17.
Other studies suggest that, to observe a chronic peri-
odontal disease and an inflammatory disease, a time range,
a different strain immunized with another inflammatory
inducer, the creation of a chronic extrasynovial lesion before
immunization [5], an acid phosphatase test, and an analysis
of a computed microtomography of the hind limb [7] are
required.
Our current findings provide critical insight into autoim-
mune function and the number of samples in our study is
statistically similar to the study of Falsetta et al. [28] and
Klein et al. [29] who used different study conditions. This
observation highlights the fundamental pathogenic role of
the P. gingivalis/T. forsythia mixture and inflammatory adju-
vants as a logical objective for increasing immunization and
oral inoculations to obtain high levels of these inflammation
modulators.
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